Foresite Capital
VC
2011
$3 500 M
San Francisco, California, United States
Investment Ticket
Investment Horizon
Investment Stage
Exit Strategy
Profile
The biggest healthcare problems won’t be solved by a typical approach.
We focus
On therapeutics, devices, diagnostics and services, and we use data science to drive much of our decision making.
We invest
In people, ideas and discoveries that could save lives and transform healthcare, and we are intrigued by the intersection between biology and big data.
FULL LIFECYCLE INVESTING
We partner at all stages – from incubation to IPO and beyond. Our goal is to have impact regardless of timing.
DEEP COLLABORATION
Our team of investment analysts, MD/PhDs and data scientists work closely with each company we invest in.
INDUSTRY KNOW-HOW
We have extensive operational and investment experience to guide our decisions and offer guidance.
EXTENSIVE NETWORKS
We have friends, partners and former colleagues throughout the healthcare ecosystem, and we consult them to help visionaries realize their dreams.
We provide complete capital solutions at all stages to help build the next category-defining companies, because value creation goes beyond the IPO.
Industry
Region of investment
Foresite Capital Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
Foresite Capital Fund III, L.P
|
Venture Capital (VC)
|
Healthcare Services
Life Sciences
|
Seed
Series A
Series B
|
North America
South America
Europe
Middle East
Africa
Asia
Australia and others
|
$5-10 m
|
$450 M
|
July 2015
|
|
Foresite Capital Fund IV, L.P
|
Venture Capital (VC)
|
Healthcare Services
Life Sciences
|
Seed
Series A
Series B
|
North America
South America
Europe
Middle East
Africa
Asia
Australia and others
|
$5-10 m
|
$668 M
|
May 2018
|
|
Foresite Capital Opportunity Fund V, L.P.
|
Venture Capital (VC)
|
Healthcare Services
Life Sciences
|
Seed
Series A
Series B
|
North America
South America
Europe
Middle East
Africa
Asia
Australia and others
|
$5-10 m
|
$186 M
|
February 2021
|
|
Foresite Capital Fund VI, L.P
|
Venture Capital (VC)
|
Healthcare Services
Life Sciences
|
Seed
Series A
Series B
|
North America
South America
Europe
Middle East
Africa
Asia
Australia and others
|
$5-10 m
|
$900 M
|
June 2024
|
|
Foresite Labs Fund
|
Fund of funds
|
Biotechnology
Healthcare Services
Medical Devices
Life Sciences
Infrastructure
|
Seed
Series A
Series B
|
North America
|
$5-10 m
|
$173 M
|
March 2022
|
|
Foresite Capital Fund V, L.P
|
Fund of funds
|
Food and Beverage
Foodtech
Technology
Life Sciences
Infrastructure
HealthTech
|
Seed
Series A
Series B
|
North America
|
$5-10 m
|
$783 M
|
February 2021
|
